Methodological problems in evaluating the role of cholinergic mechanisms in behavior.
D000109:Acetylcholine / Q000032:analysis / Q000502:physiology*; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000008:administration & dosage / Q000494:pharmacology; D001362:Avoidance Learning / Q000187:drug effects; D001519:Behavior / Q000187:drug effects*; D001812:Blood-Brain Barrier; D001923:Brain Chemistry; D001930:Brain Injuries / Q000503:physiopathology; D001931:Brain Mapping; D002490:Central Nervous System / Q000187:drug effects; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology; D010856:Columbidae; D004357:Drug Synergism; D004597:Electroshock; D000882:Haplorhini; D008568:Memory / Q000187:drug effects; D008722:Methods; D009638:Norepinephrine / Q000032:analysis; D010275:Parasympathetic Nervous System / Q000187:drug effects*; D010424:Pentobarbital / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D012054:Reinforcement, Psychology / Q000187:drug effects; D012106:Research; D012601:Scopolamine / Q000008:administration & dosage / Q000494:pharmacology; D012701:Serotonin / Q000032:analysis
D002800:Cholinesterase Inhibitors; D011725:Pyridines; D012701:Serotonin; D001285:Atropine; D000661:Amphetamine; D012601:Scopolamine; D010424:Pentobarbital; D000109:Acetylcholine; D009638:Norepinephrine